reata.net — August 2026 traffic, keywords & AI visibility

reata.net draws an estimated 25,600 visits a month from search engines. Effectively all of it is organic — about 25,600 visits from unpaid results. Spread across 910 ranking keywords, that averages roughly 28 organic visits per keyword.

On our AI visibility scale reata.net earns 59 of 100 points, a grade D. It takes full marks for LLMS.txt. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10), Company profile (19/25) and Structured data (0/5).

The llms.txt on reata.net runs to 75 lines (4,242 characters) across 12 sections, last generated in May 2026. It introduces the site as "Reata Pharmaceuticals". It tells AI engines the business works in Biotechnology, Pharmaceuticals and Clinical Research. It describes 4 products, with prices such as Clinical Trial Listings at Free and Patient Support Guides at Free. Services it lists include Partnership Development, Trial Site Support and Industry Insights Sharing. Technologies it mentions include HTTPS. The keywords it claims start with "clinical trials", "drug development", "patient resources" and "health conditions".

# Reata Pharmaceuticals

## About
Reata Pharmaceuticals focuses on developing medicines that target difficult diseases where options remain limited. Their work centers on moving compounds through the full cycle from early research into later stage testing and eventual regulatory review. Teams handle everything from molecule design to organizing clinical studies that gather real patient data. Partnerships with other biotech groups and larger pharma players help share the load on complex projects. Patients get access to resources that explain ongoing trials and what participation might involve. News updates on approvals and study results keep the wider community informed about progress. The company stays active in biotechnology circles, contributing to conversations around how new drugs reach the market. Regulatory teams track changes in approval pathways to keep development plans aligned. Collaboration extends to healthcare providers who support trial sites across different regions. Value comes from concentrating on conditions that affect smaller patient groups but carry high unmet need. Drug development follows structured stages that emphasize safety data and measurable outcomes. Internal scientists work alongside external experts to refine compounds before they enter human testing. Patient support materials cover practical questions about living with chronic illnesses tied to 

Google lists reata.net for about 910 keywords, which together bring an estimated 25,600 organic visits a month.

The latest technical audit of reata.net scored 0 out of 100 overall. The audit makes 12 recommendations in all, and 4 of the 4 listed first are rated high priority or critical.

Reata Pharmaceuticals's company profile names https://www.researchgate.net, https://www.clinicaltrials.gov, https://www.pharmaceuticalnews.com and https://www.biotechnews.com as competitors. Its own llms.txt adds https://www.drugdevelopment.com and https://www.healthcare.gov. Outside its market, the domains ranked closest to it in our worldwide ranking are grandrapidslawn.com, tactics.be, feherb.xyz and flyworldbba.com.

https://www.researchgate.net

https://www.clinicaltrials.gov

https://www.pharmaceuticalnews.com

https://www.biotechnews.com

https://www.drugdevelopment.com

https://www.healthcare.gov